Global Novel Oral Anticoagulants Drugs Supply, Demand and Key Producers, 2023-2029

Page: 99

Published Date: 09 Aug 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Novel Oral Anticoagulants Drugs market size is expected to reach $ 42300 million by 2029, rising at a market growth of 9.8% CAGR during the forecast period (2023-2029).

The antithrombotic treatment market is driven by the increasing prevalence of cardiovascular diseases and the rising aging population, which are significant risk factors for thrombotic disorders. Antithrombotic therapies, including antiplatelet and anticoagulant drugs, play a crucial role in preventing and treating thrombotic events, such as heart attacks and strokes. The growing adoption of these treatments for various thrombotic indications, along with advancements in drug development and personalized medicine, further propel market growth. However, challenges include balancing the risk of bleeding complications with the benefits of preventing thrombotic events, ensuring optimal dosing and adherence to treatment regimens, and addressing the cost burden of long-term therapy. Overcoming these challenges through continuous research, improved patient education, and collaboration between healthcare providers and pharmaceutical companies will be crucial for the sustained growth of the antithrombotic treatment market.

Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time.

This report studies the global Novel Oral Anticoagulants Drugs demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Novel Oral Anticoagulants Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Novel Oral Anticoagulants Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Novel Oral Anticoagulants Drugs total market, 2018-2029, (USD Million)
Global Novel Oral Anticoagulants Drugs total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Novel Oral Anticoagulants Drugs total market, key domestic companies and share, (USD Million)
Global Novel Oral Anticoagulants Drugs revenue by player and market share 2018-2023, (USD Million)
Global Novel Oral Anticoagulants Drugs total market by Type, CAGR, 2018-2029, (USD Million)
Global Novel Oral Anticoagulants Drugs total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Novel Oral Anticoagulants Drugs market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bristol-Myers Squibb, Bayer, Pfizer, Johnson & Johnson, Boehringer Ingelheim and Daiichi Sankyo, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Novel Oral Anticoagulants Drugs market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Novel Oral Anticoagulants Drugs Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Novel Oral Anticoagulants Drugs Market, Segmentation by Type
Direct Thrombin Inhibitor
Factor Xa Inhibitors

Global Novel Oral Anticoagulants Drugs Market, Segmentation by Application
Hospital
Drugs Stores
Other

Companies Profiled:
Bristol-Myers Squibb
Bayer
Pfizer
Johnson & Johnson
Boehringer Ingelheim
Daiichi Sankyo

Key Questions Answered
1. How big is the global Novel Oral Anticoagulants Drugs market?
2. What is the demand of the global Novel Oral Anticoagulants Drugs market?
3. What is the year over year growth of the global Novel Oral Anticoagulants Drugs market?
4. What is the total value of the global Novel Oral Anticoagulants Drugs market?
5. Who are the major players in the global Novel Oral Anticoagulants Drugs market?

Table of Contents

1 Supply Summary
    1.1 Novel Oral Anticoagulants Drugs Introduction
    1.2 World Novel Oral Anticoagulants Drugs Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Novel Oral Anticoagulants Drugs Total Market by Region (by Headquarter Location)
        1.3.1 World Novel Oral Anticoagulants Drugs Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Novel Oral Anticoagulants Drugs Market Size (2018-2029)
        1.3.3 China Novel Oral Anticoagulants Drugs Market Size (2018-2029)
        1.3.4 Europe Novel Oral Anticoagulants Drugs Market Size (2018-2029)
        1.3.5 Japan Novel Oral Anticoagulants Drugs Market Size (2018-2029)
        1.3.6 South Korea Novel Oral Anticoagulants Drugs Market Size (2018-2029)
        1.3.7 ASEAN Novel Oral Anticoagulants Drugs Market Size (2018-2029)
        1.3.8 India Novel Oral Anticoagulants Drugs Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Novel Oral Anticoagulants Drugs Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Novel Oral Anticoagulants Drugs Major Market Trends

2 Demand Summary
    2.1 World Novel Oral Anticoagulants Drugs Consumption Value (2018-2029)
    2.2 World Novel Oral Anticoagulants Drugs Consumption Value by Region
        2.2.1 World Novel Oral Anticoagulants Drugs Consumption Value by Region (2018-2023)
        2.2.2 World Novel Oral Anticoagulants Drugs Consumption Value Forecast by Region (2024-2029)
    2.3 United States Novel Oral Anticoagulants Drugs Consumption Value (2018-2029)
    2.4 China Novel Oral Anticoagulants Drugs Consumption Value (2018-2029)
    2.5 Europe Novel Oral Anticoagulants Drugs Consumption Value (2018-2029)
    2.6 Japan Novel Oral Anticoagulants Drugs Consumption Value (2018-2029)
    2.7 South Korea Novel Oral Anticoagulants Drugs Consumption Value (2018-2029)
    2.8 ASEAN Novel Oral Anticoagulants Drugs Consumption Value (2018-2029)
    2.9 India Novel Oral Anticoagulants Drugs Consumption Value (2018-2029)

3 World Novel Oral Anticoagulants Drugs Companies Competitive Analysis
    3.1 World Novel Oral Anticoagulants Drugs Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Novel Oral Anticoagulants Drugs Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Novel Oral Anticoagulants Drugs in 2022
        3.2.3 Global Concentration Ratios (CR8) for Novel Oral Anticoagulants Drugs in 2022
    3.3 Novel Oral Anticoagulants Drugs Company Evaluation Quadrant
    3.4 Novel Oral Anticoagulants Drugs Market: Overall Company Footprint Analysis
        3.4.1 Novel Oral Anticoagulants Drugs Market: Region Footprint
        3.4.2 Novel Oral Anticoagulants Drugs Market: Company Product Type Footprint
        3.4.3 Novel Oral Anticoagulants Drugs Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Novel Oral Anticoagulants Drugs Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Novel Oral Anticoagulants Drugs Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Novel Oral Anticoagulants Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Novel Oral Anticoagulants Drugs Consumption Value Comparison
        4.2.1 United States VS China: Novel Oral Anticoagulants Drugs Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Novel Oral Anticoagulants Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Novel Oral Anticoagulants Drugs Companies and Market Share, 2018-2023
        4.3.1 United States Based Novel Oral Anticoagulants Drugs Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Novel Oral Anticoagulants Drugs Revenue, (2018-2023)
    4.4 China Based Companies Novel Oral Anticoagulants Drugs Revenue and Market Share, 2018-2023
        4.4.1 China Based Novel Oral Anticoagulants Drugs Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Novel Oral Anticoagulants Drugs Revenue, (2018-2023)
    4.5 Rest of World Based Novel Oral Anticoagulants Drugs Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Novel Oral Anticoagulants Drugs Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Novel Oral Anticoagulants Drugs Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Novel Oral Anticoagulants Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Direct Thrombin Inhibitor
        5.2.2 Factor Xa Inhibitors
    5.3 Market Segment by Type
        5.3.1 World Novel Oral Anticoagulants Drugs Market Size by Type (2018-2023)
        5.3.2 World Novel Oral Anticoagulants Drugs Market Size by Type (2024-2029)
        5.3.3 World Novel Oral Anticoagulants Drugs Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Novel Oral Anticoagulants Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Drugs Stores
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World Novel Oral Anticoagulants Drugs Market Size by Application (2018-2023)
        6.3.2 World Novel Oral Anticoagulants Drugs Market Size by Application (2024-2029)
        6.3.3 World Novel Oral Anticoagulants Drugs Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Bristol-Myers Squibb
        7.1.1 Bristol-Myers Squibb Details
        7.1.2 Bristol-Myers Squibb Major Business
        7.1.3 Bristol-Myers Squibb Novel Oral Anticoagulants Drugs Product and Services
        7.1.4 Bristol-Myers Squibb Novel Oral Anticoagulants Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Bristol-Myers Squibb Recent Developments/Updates
        7.1.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
    7.2 Bayer
        7.2.1 Bayer Details
        7.2.2 Bayer Major Business
        7.2.3 Bayer Novel Oral Anticoagulants Drugs Product and Services
        7.2.4 Bayer Novel Oral Anticoagulants Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Bayer Recent Developments/Updates
        7.2.6 Bayer Competitive Strengths & Weaknesses
    7.3 Pfizer
        7.3.1 Pfizer Details
        7.3.2 Pfizer Major Business
        7.3.3 Pfizer Novel Oral Anticoagulants Drugs Product and Services
        7.3.4 Pfizer Novel Oral Anticoagulants Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Pfizer Recent Developments/Updates
        7.3.6 Pfizer Competitive Strengths & Weaknesses
    7.4 Johnson & Johnson
        7.4.1 Johnson & Johnson Details
        7.4.2 Johnson & Johnson Major Business
        7.4.3 Johnson & Johnson Novel Oral Anticoagulants Drugs Product and Services
        7.4.4 Johnson & Johnson Novel Oral Anticoagulants Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Johnson & Johnson Recent Developments/Updates
        7.4.6 Johnson & Johnson Competitive Strengths & Weaknesses
    7.5 Boehringer Ingelheim
        7.5.1 Boehringer Ingelheim Details
        7.5.2 Boehringer Ingelheim Major Business
        7.5.3 Boehringer Ingelheim Novel Oral Anticoagulants Drugs Product and Services
        7.5.4 Boehringer Ingelheim Novel Oral Anticoagulants Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Boehringer Ingelheim Recent Developments/Updates
        7.5.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
    7.6 Daiichi Sankyo
        7.6.1 Daiichi Sankyo Details
        7.6.2 Daiichi Sankyo Major Business
        7.6.3 Daiichi Sankyo Novel Oral Anticoagulants Drugs Product and Services
        7.6.4 Daiichi Sankyo Novel Oral Anticoagulants Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Daiichi Sankyo Recent Developments/Updates
        7.6.6 Daiichi Sankyo Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Novel Oral Anticoagulants Drugs Industry Chain
    8.2 Novel Oral Anticoagulants Drugs Upstream Analysis
    8.3 Novel Oral Anticoagulants Drugs Midstream Analysis
    8.4 Novel Oral Anticoagulants Drugs Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Novel Oral Anticoagulants Drugs Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Novel Oral Anticoagulants Drugs Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Novel Oral Anticoagulants Drugs Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Novel Oral Anticoagulants Drugs Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Novel Oral Anticoagulants Drugs Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Novel Oral Anticoagulants Drugs Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Novel Oral Anticoagulants Drugs Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Novel Oral Anticoagulants Drugs Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Novel Oral Anticoagulants Drugs Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Novel Oral Anticoagulants Drugs Players in 2022
    Table 12. World Novel Oral Anticoagulants Drugs Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Novel Oral Anticoagulants Drugs Company Evaluation Quadrant
    Table 14. Head Office of Key Novel Oral Anticoagulants Drugs Player
    Table 15. Novel Oral Anticoagulants Drugs Market: Company Product Type Footprint
    Table 16. Novel Oral Anticoagulants Drugs Market: Company Product Application Footprint
    Table 17. Novel Oral Anticoagulants Drugs Mergers & Acquisitions Activity
    Table 18. United States VS China Novel Oral Anticoagulants Drugs Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Novel Oral Anticoagulants Drugs Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Novel Oral Anticoagulants Drugs Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Novel Oral Anticoagulants Drugs Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Novel Oral Anticoagulants Drugs Revenue Market Share (2018-2023)
    Table 23. China Based Novel Oral Anticoagulants Drugs Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Novel Oral Anticoagulants Drugs Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Novel Oral Anticoagulants Drugs Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Novel Oral Anticoagulants Drugs Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Novel Oral Anticoagulants Drugs Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Novel Oral Anticoagulants Drugs Revenue Market Share (2018-2023)
    Table 29. World Novel Oral Anticoagulants Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Novel Oral Anticoagulants Drugs Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Novel Oral Anticoagulants Drugs Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Novel Oral Anticoagulants Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Novel Oral Anticoagulants Drugs Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Novel Oral Anticoagulants Drugs Market Size by Application (2024-2029) & (USD Million)
    Table 35. Bristol-Myers Squibb Basic Information, Area Served and Competitors
    Table 36. Bristol-Myers Squibb Major Business
    Table 37. Bristol-Myers Squibb Novel Oral Anticoagulants Drugs Product and Services
    Table 38. Bristol-Myers Squibb Novel Oral Anticoagulants Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Bristol-Myers Squibb Recent Developments/Updates
    Table 40. Bristol-Myers Squibb Competitive Strengths & Weaknesses
    Table 41. Bayer Basic Information, Area Served and Competitors
    Table 42. Bayer Major Business
    Table 43. Bayer Novel Oral Anticoagulants Drugs Product and Services
    Table 44. Bayer Novel Oral Anticoagulants Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Bayer Recent Developments/Updates
    Table 46. Bayer Competitive Strengths & Weaknesses
    Table 47. Pfizer Basic Information, Area Served and Competitors
    Table 48. Pfizer Major Business
    Table 49. Pfizer Novel Oral Anticoagulants Drugs Product and Services
    Table 50. Pfizer Novel Oral Anticoagulants Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Pfizer Recent Developments/Updates
    Table 52. Pfizer Competitive Strengths & Weaknesses
    Table 53. Johnson & Johnson Basic Information, Area Served and Competitors
    Table 54. Johnson & Johnson Major Business
    Table 55. Johnson & Johnson Novel Oral Anticoagulants Drugs Product and Services
    Table 56. Johnson & Johnson Novel Oral Anticoagulants Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Johnson & Johnson Recent Developments/Updates
    Table 58. Johnson & Johnson Competitive Strengths & Weaknesses
    Table 59. Boehringer Ingelheim Basic Information, Area Served and Competitors
    Table 60. Boehringer Ingelheim Major Business
    Table 61. Boehringer Ingelheim Novel Oral Anticoagulants Drugs Product and Services
    Table 62. Boehringer Ingelheim Novel Oral Anticoagulants Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Boehringer Ingelheim Recent Developments/Updates
    Table 64. Daiichi Sankyo Basic Information, Area Served and Competitors
    Table 65. Daiichi Sankyo Major Business
    Table 66. Daiichi Sankyo Novel Oral Anticoagulants Drugs Product and Services
    Table 67. Daiichi Sankyo Novel Oral Anticoagulants Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 68. Global Key Players of Novel Oral Anticoagulants Drugs Upstream (Raw Materials)
    Table 69. Novel Oral Anticoagulants Drugs Typical Customers
List of Figure
    Figure 1. Novel Oral Anticoagulants Drugs Picture
    Figure 2. World Novel Oral Anticoagulants Drugs Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Novel Oral Anticoagulants Drugs Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Novel Oral Anticoagulants Drugs Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Novel Oral Anticoagulants Drugs Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Novel Oral Anticoagulants Drugs Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Novel Oral Anticoagulants Drugs Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Novel Oral Anticoagulants Drugs Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Novel Oral Anticoagulants Drugs Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Novel Oral Anticoagulants Drugs Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Novel Oral Anticoagulants Drugs Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Novel Oral Anticoagulants Drugs Revenue (2018-2029) & (USD Million)
    Figure 13. Novel Oral Anticoagulants Drugs Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Novel Oral Anticoagulants Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Novel Oral Anticoagulants Drugs Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Novel Oral Anticoagulants Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Novel Oral Anticoagulants Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Novel Oral Anticoagulants Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Novel Oral Anticoagulants Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Novel Oral Anticoagulants Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Novel Oral Anticoagulants Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Novel Oral Anticoagulants Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Novel Oral Anticoagulants Drugs by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Novel Oral Anticoagulants Drugs Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Novel Oral Anticoagulants Drugs Markets in 2022
    Figure 27. United States VS China: Novel Oral Anticoagulants Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Novel Oral Anticoagulants Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Novel Oral Anticoagulants Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Novel Oral Anticoagulants Drugs Market Size Market Share by Type in 2022
    Figure 31. Direct Thrombin Inhibitor
    Figure 32. Factor Xa Inhibitors
    Figure 33. World Novel Oral Anticoagulants Drugs Market Size Market Share by Type (2018-2029)
    Figure 34. World Novel Oral Anticoagulants Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 35. World Novel Oral Anticoagulants Drugs Market Size Market Share by Application in 2022
    Figure 36. Hospital
    Figure 37. Drugs Stores
    Figure 38. Other
    Figure 39. Novel Oral Anticoagulants Drugs Industrial Chain
    Figure 40. Methodology
    Figure 41. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Bristol-Myers Squibb
Bayer
Pfizer
Johnson & Johnson
Boehringer Ingelheim
Daiichi Sankyo

Related Reports

Global Novel Oral Anticoagulants Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Global Novel Oral Anticoagulants Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

date 12 Feb 2021

date Pharma & Healthcare

The Novel Oral Anticoagulants Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Novel Oral Anticoagulants Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Novel Oral Anticoagulants Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 16 Jan 2022

date Pharma & Healthcare

Global Novel Oral Anticoagulants Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Novel Oral Anticoagulants Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 11 Jan 2023

date Pharma & Healthcare

Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time.

Global Novel Oral Anticoagulants Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Novel Oral Anticoagulants Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 09 Aug 2023

date Medical Care

According to our (Global Info Research) latest study, the global Novel Oral Anticoagulants Drugs market size was valued at USD 22040 million in 2022 and is forecast to a readjusted size of USD 42300 million by 2029 with a CAGR of 9.8% during review period.

Global Novel Oral Anticoagulants Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Novel Oral Anticoagulants Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Novel Oral Anticoagulants Drugs market size was valued at USD 22040 million in 2023 and is forecast to a readjusted size of USD 42300 million by 2030 with a CAGR of 9.8% during review period.

Product Tags

novel oral anticoagulants drugs

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>